Press Releases
Samsung Biologics signs a Strategic Manufacturing Partnership with Roche
Seoul(Korea) Oct 22th, 2013 ? Samsung Biologics and F.Hoffmann-La Roche today announced that they have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche;s proprietary commercial biologics medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.
Seoul(Korea) Oct 22th, 2013 – Samsung Biologics and F.Hoffmann-La Roche today announced that they have entered into a long term strategic manufacturing agreement under which Samsung will manufacture Roche;s proprietary commercial biologics medicines at its two manufacturing facilities in Incheon, South Korea, of which one is currently under construction.